Verrica Pharmaceuticals Inc

NASDAQ:VRCA   3:59:59 PM EDT
7.62
-0.13 (-1.68%)
Products

Verrica Pharmaceuticals Announces Acceptance By FDA Of NDA Resubmission For VP-102

Published: 12/15/2021 22:40 GMT
Verrica Pharmaceuticals Inc (VRCA) - Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for Vp-102 for the Treatment of Molluscum Contagiosum.
Verrica Pharmaceuticals Inc - FDA Assigned a Prescription Drug User Fee Act Goal Date of May 24, 2022.